- A20 -

Correcting the Record Addressing The New York Times Deceptive Coverage of Psymposia by Psymposia Rather than unpacking the actual causes of Lykos Therapeutics disastrous Phase 3 trials and FDA rejection The New York Times produced a work of fictitious propaganda that prioritizes corporate interests over public health. Correcting the Record Addressing The New York Times Deceptive Coverage of Psymposia by Psymposia Rather than unpacking the actual causes of Lykos Therapeutics disastrous Phase 3 trials and FDA rejection The New York Times produced a work of fictitious propaganda that prioritizes corporate interests over public health. Psymposia is a 501c3 nonprofit media organization that offers critical perspectives on drugs politics and culture. We are sustained by our readers and listeners who believe in the work we do.